Russian central bank: Russia's current account surplus in November was $3.2 billion.Traders' interest rate expectations for the European Central Bank remain stable: it is expected to cut interest rates by 127 basis points in 2025.ECB: There is no pre-commitment to a specific interest rate path. The investment portfolio of the asset purchase plan declines at a controllable and predictable rate.
South Korea's finance ministers and Japan's finance ministers held an online meeting, and the two sides reiterated the importance of the partnership between the two countries.Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement.The Israeli army launched several rounds of air strikes on many places in Gaza, resulting in 37 deaths. On December 12, local time, the reporter of the General Station was informed that the Israeli army launched several rounds of air strikes on Gaza City in the north, Nuseilet refugee camp in the middle and Khan Younis in the south of the Gaza since the early morning of that day, which has caused 37 deaths. At present, the Israeli side has not issued a statement on related events. (CCTV News)
Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).The main fuel contract rose by 6.00% in the day and is now reported at 3249.00 yuan/ton.Guoxuan Hi-Tech: China, the strategic shareholder, continued to give up voting rights. Guoxuan Hi-Tech announced that Guoxuan Holdings, Li Zhen and Jerry Lee (collectively referred to as the "founding shareholders") and China, the strategic shareholder of the company, signed a Supplementary Agreement on the Shareholders' Agreement of Guoxuan Hi-Tech Co., Ltd., and Volkswagen China agreed to extend the commitment period of giving up voting rights. That is to say, within 72 months after the relevant shares of the company involved in the non-public offering and share transfer are registered in the name of Volkswagen China or within a longer period determined by Volkswagen China, it will irrevocably give up the voting rights of some of its shares in the company, so that the voting rights of Volkswagen China will be at least 5% lower than that of the founding shareholder. Volkswagen China's extension of the period of giving up its voting rights commitment this time will not lead to the change of the company's control rights and will not affect the normal production and operation of the company. Mr. Li Zhen remains the actual controller of the company.
Strategy guide
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13